SGLT2 Inhibitors vs. Finerenone for Slowing CKD Progression in Hypertensive Diabetic Patients with Obesity: A Comparative Effectiveness Study. JAPMI. 2024;2(1):21-236. doi:10.60087/Japmi.Vol.02.Issue.01.Id.016